Biotech | March 07, 2024
Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Acquisition of exclusive commercialization rights for European markets
Connecting new production and consumption areas of chilled food by low-carbon transportation services
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to US$ 9.13 million
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Subscribe To Our Newsletter & Stay Updated
